InsidersTradesSigma
Follow the EMR share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Market capitalisation: €3.8bn. The latest transaction was filed on 5 June 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is free.
Analysts rate EMR Buy (bullish), based on 3 analysts. Average price target: A$7.87.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
EMR is a company listed on the XASX, specializing in the financial sector.